Among its subtypes, triple-negative breast cancer (TNBC), distinguished by the absence of oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression [26], and is associated with aggressive clinical behaviour, limited treatment options, and poor prognosis. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.